Company Filing History:
4 out of 230 
3 out of 1,745 
2 out of 15 
Years Active: 2017-2025
Title: The Innovations of Benjamin Guillet
Introduction
Benjamin Guillet is a notable inventor based in Aix en Provence, France. He has made significant contributions to the fields of medicine and biotechnology, particularly in the diagnosis and treatment of fibrosis and cancer. With a total of 4 patents, Guillet's work has the potential to impact patient care and therapeutic strategies.
Latest Patents
Guillet's latest patents include groundbreaking inventions related to CD146. One patent focuses on the use of CD146 as a biomarker and therapeutic target in the diagnosis and treatment of fibrosis. This invention encompasses methods for detecting predisposition to, diagnosing, prognosing, and monitoring fibrosis in subjects. Additionally, it includes compositions and inhibitors aimed at preventing or treating fibrosis. Another significant patent involves anti-CD146 antibodies, which are directed specifically at CD146-positive tumors. This invention has applications in the prevention and treatment of various cancers, including melanoma, pancreatic cancer, kidney cancer, and colon cancer.
Career Highlights
Throughout his career, Benjamin Guillet has worked with esteemed institutions such as Université d'Aix-Marseille and the Institut National de la Santé et de la Recherche Médicale. His research has contributed to advancements in medical diagnostics and therapeutic approaches.
Collaborations
Guillet has collaborated with notable colleagues, including Marcel Blot-Chabaud and Nathalie Bardin. These partnerships have fostered innovation and enhanced the impact of his research.
Conclusion
Benjamin Guillet's contributions to medical science through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in the diagnosis and treatment of critical health conditions.